Professor Valerie Mizrahi
Professor Valerie Mizrahi PhD (UCT) OMS MASSAf FRSSAf FAAM Fellow of UCT
Director, UCT Molecular Mycobacteriology Research Unit (MMRU) and Co-Director, DSI/NRF Centre of Excellence for Biomedical TB Research (CBTBR); Faculty of Health Sciences, University of Cape Town; Emeritus Member, Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) and former Senior International Research Scholar, Howard Hughes Medical Institute, United States of America (US) to October 2017.
Received the L'Oréal-UNESCO Award for Women in Science (2000); the Gold Medal from the South African Society for Biochemistry and Molecular Biology for her contributions to the field (2006); the Department of Science and Technology's Distinguished Woman Scientist Award (2006); named to the Order of Mapungubwe (2007); awarded the Institut de France's Christophe Mérieux Prize for her work in tuberculosis research (2013), Platinum Medal of the SAMRC for lifetime contributions to medical research in South Africa (2017), and Harry Oppenheimer Fellowship (2018). Recognised as a leader in her field, she has held an “A” rating from National Research Foundation in 2009, with her A1 rating re-awarded in 2021. Serves on the Discovery Expert Group of the Bill & Melinda Gates Foundation (BMGF), the Scientific Advisory Boards of the Ragon Institute of MGH, Harvard & MIT, the Max Planck Institute for Infection Biology and the Seattle TB Research Advancement Centre (University of Washington), the Portfolio Management Team of the TB Drug Accelerator (Bill & Melinda Gates Foundation)) and the Board of Governors of the Tres Cantos Open Lab Foundation.
See publications and profile on Research Gate.
Contact details:
WBS 3.17, Wernher & Beit Building South
Institute of Infectious Disease and Molecular Medicine
UCT Faculty of Health Sciences
Anzio Road, Observatory 7925
South Africa
Tel: +27 21 4066098
Fax: +27 21 4066068
Email: valerie.mizrahi@uct.ac.za
Group members:
| Member | Position |
| Digby Warner | Deputy Director, MMRU |
| Melissa Chengalroyen | Research Officer |
| Sophia Gessner | Research Officer |
| Atica Moosa | Research Officer |
| Mandy Mason | Research Officer |
| Anastasia Koch | Honorary Research Associate |
| Charles Omollo | Junior Research fellow |
| Dharanidharan Ramamurthy | Postdoctoral fellow |
| Ryan Dinkele | PhD (Medical Microbiology) |
| Jospeh Gitari | PhD (Medical Microbiology) |
| Zela Martin | PhD (Medical Microbiology) |
| Tshepiso Nkonyane | PhD (Medical Microbiology) |
| Ditshego Ralefeta | PhD (Medical Microbiology) |
| Atondaho Ramudzuli | PhD (Medical Microbiology) |
| Lucas Raphela | PhD (Medical Microbiology) |
| Veneshley Samuels | PhD (Medical Microbiology) |
| Kristin Winckler | PhD (Medical Microbiology) |
| Audrey Jordaan | Senior Lab Technologist |
| Sasha-Lee Lynch | BSLIII Lab Technologist |
| Charmaine McBride |
Administrative Assistant |
Collaborations:
International:
Dr Kyu Rhee (Weill Cornell Medical College), Dr D. Branch Moody (Brigham & Women’s Hospital), Dr Jeremy Rock (Rockefeller University) and other members of the Myco3V TBRU consortium
Dr Meindert Lamers, Leiden University Medical Centre, The Netherlands
Dr Clifton E. Barry III and Dr Helena Boshoff, NIAID, NIH, USA
Dr Laura Cleghorn and Gareth Prosser, Drug Discovery Unit, University of Dundee
Prof David Lewinsohn and Prof Deborah Lewinsohn, Oregon health Sciences University
Dr Karen Dobos, Colorado State University
Prof Umesh Varshney, Indian Institute of Science, Bengaluru, India
Prof Rolf Müller, Prof Anna Hirsch and Dr Jennifer Hermann, Helmholtz Institute for Pharmaceutical Research, Saarland
Dr David Olsen, Merck Research Laboratories, USA
Local:
Prof Erick Strauss, Stellenbosch University